Ghrelin and growth hormone (GH) secretagogue receptor (GHSR) mRNA expression in human pituitary adenomas
- 1 June 2001
- journal article
- research article
- Published by Wiley in Clinical Endocrinology
- Vol. 54 (6) , 759-768
- https://doi.org/10.1046/j.1365-2265.2001.01286.x
Abstract
OBJECTIVE The level of growth hormone (GH), growth hormone secretogogue (GHS) and GHS receptor (GHSR) messenger ribonucleic acid (mRNA) expression has been reported as being higher in GH‐producing pituitary adenomas than in other types of pituitary adenomas. Recently, ghrelin, an endogenous ligand specific for GHSR, was isolated. Therefore, we attempted to clarify whether ghrelin mRNA is expressed in various types of human pituitary adenoma by competitive reverse transcription‐polymerase chain reaction (RT‐PCR). We also examined the relationship between the levels of ghrelin or GHSR mRNA and hormonal and tumour characteristics in patients with pituitary adenomas. PATIENTS Pituitary adenoma tissue was obtained at surgery from 13 patients with acromegaly, 4 with prolactinomas, 5 with gonadotrophin (Gn)‐producing adenomas, 4 with non‐functioning adenomas, 2 with ACTH‐producing adenomas and 2 with TSH‐producing adenomas. METHODS The expression levels of human ghrelin mRNA and GHSR mRNA were quantified using a competitive RT‐PCR method. RESULTS Ghrelin mRNA was detected in all pituitary adenoma tissues examined, with the highest mean level detected in non‐functioning adenomas, a moderate level in GH‐producing adenomas and Gn‐producing adenomas, and the lowest level in prolactinomas. The level of ghrelin mRNA expression in GH‐producing adenomas correlated negatively with the size of the adenoma (n = 13) (r = − 0·756, P = 0·0028). Furthermore, the mean level of ghrelin mRNA expression in high‐grade (III and IV of Hardy classification) GH‐producing adenomas was significantly lower than that in low‐grade (I and II) GH‐producing adenomas (P = 0·0016). GHSR mRNA was also detected in all pituitary adenomas with the highest mean level in GH‐producing adenomas, a moderate level in nonfunctioning adenoma, and the lowest level in prolactinoma and Gn‐producing adenomas. CONCLUSIONS Ghrelin mRNA, in addition to GHSR mRNA, is expressed in various types of pituitary adenoma with different levels of expression in each type. Our findings suggest that ghrelin produced in pituitary adenoma may play some role in the mechanism underlying the development of adenoma cells through autocrine and/or paracrine pathways.Keywords
This publication has 36 references indexed in Scilit:
- Pituitary Somatotroph Adenoma Producing Growth Hormone (GH)-Releasing Hormone (GHRH) with an Elevated Plasma GHRH Concentration: A Model Case for Autocrine and Paracrine Regulation of GH Secretion by GHRHJournal of Clinical Endocrinology & Metabolism, 1999
- Growth Hormone (GH)-Releasing Hormone (GHRH) and the GH Secretagogue (GHS), L692,585, Differentially Modulate Rat Pituitary GHS Receptor and GHRH Receptor Messenger Ribonucleic Acid LevelsEndocrinology, 1999
- Expression Of Functional Growth Hormone Secretagogue Receptors In Human Pituitary Adenomas: Polymerase Chain Reaction, Triple In‐situ Hybridization And Cell Culture Studies 1Journal of Neuroendocrinology, 1999
- A New Orphan Receptor Involved in Pulsatile Growth Hormone ReleaseTrends in Endocrinology & Metabolism, 1999
- Growth Hormone Secretagogue Receptor Expression in Human Pituitary TumorsJournal of Clinical Endocrinology & Metabolism, 1998
- Secretory Mechanisms of Growth Hormone (GH)-Releasing Peptide-, GH-Releasing Hormone-, and Thyrotropin-Releasing Hormone-Induced GH Release in Patients with AcromegalyJournal of Clinical Endocrinology & Metabolism, 1998
- Gene Transcription of Receptors for Growth Hormone-Releasing Peptide and Somatostatin in Human Pituitary AdenomasJournal of Clinical Endocrinology & Metabolism, 1998
- Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection: evidence that GHRP- 6 main action is exerted at the hypothalamic levelJournal of Clinical Endocrinology & Metabolism, 1995
- The Growth Hormone Secretagogue, L-692,429, Induces Phosphatidylinositol Hydrolysis and Hormone Secretion by Human Pituitary TumorsBiochemical and Biophysical Research Communications, 1995
- Growth Hormone Releasing Hexapeptide (GHRP-6) Activates the Inositol (1,4,5)-Trisphosphate/Diacylglycerol Pathway in Rat Anterior Pituitary CellsJournal of Receptors and Signal Transduction, 1995